Contact
Please use this form to send email to PR contact of this press release:
GSK announces start of phase III programme for mepolizumab in patients with COPD
TO:
Please use this form to send email to PR contact of this press release:
GSK announces start of phase III programme for mepolizumab in patients with COPD
TO: